Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates Guidance

Forge Nano (NANO) reported Q3 2026 results, raising $130M in its Nasdaq debut. The company expanded into pharmaceuticals via a joint deal with Nanexa, completed the HZO acquisition, and broke ground on a $400M-$665M battery gigafactory. It expects $18M revenue, $12.7M grants, and $9.4M HZO revenue for 2026.

Original reporting
Published Nov 16, 2026, 5:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 5:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates Guidance — source image
Decision brief

The 30-second read

$NANOBullishMed
01

Why it matters

The article combines a fresh capital raise, a completed acquisition (HZO), capacity expansion for TEPHRA ALD systems, and a reiterated 2026 outlook with specific revenue and grant assumptions, which can change valuation expectations and near-term risk perception.

02

Market read

For NANO, the combination of listing-related funding, a completed acquisition, and reiterated 2026 outlook provides multiple near-term catalysts that can drive trading interest, though much of the largest revenue potential is dependent on later ramp timelines.

03

What to watch

All-stock acquisition accounting and integration timing could dilute near-term margins; pharma vertical is described as early stage, and the outlook includes grant income classification differences under GAAP.

Relevance 8/10Novelty 7/10Timing: post-market release today, for positioning ahead of next filings/updates

Background

Forge Nano is a U.S. ALD technology company that began Nasdaq trading in late October 2026 after a business combination, and is expanding across semiconductors, batteries, coatings, and pharma manufacturing.

Company-level read

Ticker impact

$NANOBullishMedium confidence
Context

Forge Nano reports Q3 2026 results, began Nasdaq trading as NANO on Oct. 22, raised over $130M, and completed the HZO acquisition.

Expected impact

Likely upward bias as investors price in stronger funding and expanded coatings capabilities, tempered by uncertainty around ramp timing and consolidation impact.

Evidence & confidence

The article discloses multiple company-specific catalysts (Nasdaq listing and $130M gross proceeds, all-stock HZO acquisition, capacity expansion, and 2026 outlook figures), which are typically supportive for a small-cap growth name, though much of the revenue potential is tied to future start-up (battery production planned for 2028).

Market effects

Reinforces demand signals for ALD equipment and advanced coatings across semiconductors, batteries, and emerging pharma manufacturing.

Highlights U.S. battery manufacturing buildout in North Carolina, potentially supportive for regional industrial supply chains.

Points to global pharma developer partnerships (Novo Nordisk and Moderna via Nanexa) and cross-border manufacturing scale-up for ALD coatings.

Counterpoint

The headline revenue potential (battery gigafactory) is scenario-based and tied to 2028 start-up, so near-term fundamentals may not improve as quickly as the narrative suggests.

Key entities

  • Forge Nano Holdings, Inc.

    Subject of the article, reporting Q3 2026 results, Nasdaq listing details, $130M+ gross proceeds, HZO acquisition completion, and 2026 outlook.

  • HZO

    Protective nanocoatings provider acquired by Forge Nano in an all-stock transaction completed Nov. 4, 2026.

  • Nanexa

    Partner under a joint development agreement for GMP-compliant ALD manufacturing for the PharmaShell platform.

  • Samsung SDI

    Supports the Morrisville battery plant setup with a $20M strategic investment and a conditional cell purchase agreement starting in 2028.

  • Novo Nordisk

    Referenced as part of a global license with Nanexa for long-acting obesity and diabetes treatments.

Related articles

$NANOHigh

Forge Nano Holdings, Inc. (NANO): Completion of Acquisition or Disposition of Assets

Forge Nano Holdings, Inc. (NANO) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 1.01. Entry into a Material Definitive Agreement. Agreement and Plan of Merger Merger Agreement On November 4, 2026, Forge Nano Holdings, Inc., a Delaware corporation (“Forge Nano”), FN Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Forge Nano (“Me

$NANOHighAI 8/10

Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets

Forge Nano (NASDAQ: NANO) completed its acquisition of HZO, a provider of protective nanocoatings for electronics. The deal, valued at 7.3 million shares, combines Forge Nano's ALD technology with HZO's Parylene and thin-film coatings, aiming to offer comprehensive surface engineering solutions. The acquisition is expected to bring operational efficiencies and expand customer reach in electronics, energy, IoT, medical, and automotive markets.

$NANOMed

Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets

Forge Nano Holdings, Inc. (NANO) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 FOR IMMEDIATE RELEASE Forge Nano Completes Acquisition of HZO, Uniting Two Nanoscale Coating Platforms for Electronics, Semiconductor and Defense Markets Combination pairs Forge Nano’s Atomic Armor atomic layer deposition (ALD) platform with HZO’s high-volume Parylen